FOLH1 and prostate carcinoma: Similarly, 68Ga‐labelled prostate‐specific membrane antigen (PSMA) used to image prostate cancer may be falsely negative in the liver where a high background activity can potentially obscure lesions, or when liver metastases tend to lose PSMA‐expression in advanced metastatic disease.